Centre Hospitalier Universitaire De Toulouse

Clinical research in the Service Pneumologie focuses strongly on cancer, especially non-small cell lung cancer and small cell lung cancer. These studies are designed to evaluate new treatment strategies, compare them with current standards, and better understand how to improve survival for people with advanced lung tumors.

• Studies in non-small cell lung cancer are assessing maintenance treatment approaches and combination therapies to improve disease control.
• Research in small cell lung cancer is comparing novel options with standard care to extend overall survival.
• Several trials are aimed at testing whether newer immunotherapy-based approaches can slow cancer progression more effectively.

This work highlights the site’s active role in advancing oncology care through trials that seek to refine treatment effectiveness and support better outcomes for patients.

Alongside oncology, the site also conducts studies in immune system diseases, with a focus on hidradenitis suppurativa. This research is centered on evaluating new therapies that may reduce symptoms, improve disease control, and offer more effective options for patients living with this chronic inflammatory condition.

• Trials in hidradenitis suppurativa are examining whether emerging treatments can improve both effectiveness and safety.
• The research aims to support better management of a painful, long-term inflammatory skin disease.

These studies show that Centre Hospitalier Universitaire De Toulouse is contributing not only to cancer research but also to the development of improved treatments for complex inflammatory disorders.